Medical Devices Startups
6,041 companies tagged Medical Devices, with their investors and founders.
CroΓValve develops the DUO System, a minimally invasive heart valve device designed to treat tricuspid regurgitation, a common and often underdiagnosed heart condition. The company targets patients suffering from this disease across the US and Europe.
2 investors
Crossbow Therapeutics develops TCR-mimetic antibody therapies designed to target cancer antigens by mimicking T-cell receptors, with a focus on treating solid tumors and hematologic malignancies. The company creates next-generation T-cell engagers incorporating its proprietary T-Boltβ’ molecules to enhance therapeutic potency and manufacturability.
2 investors
Cryosa develops an incisionless medical treatment that uses controlled cooling to reduce tissue and open airways. The company serves patients requiring airway management procedures.
2 investors
Cullinan Therapeutics is a clinical-stage biotech company developing therapeutic molecules for autoimmune diseases and cancer, with expertise in immune modulation. The company focuses on first- or best-in-class treatments to improve outcomes for patients managing these conditions.
2 investors
Cumulus Neuroscience develops NeuLogiq, a platform combining portable EEG headsets and AI-powered analytics to capture objective measures of brain function for clinical trials and patient monitoring. The platform serves pharmaceutical companies and clinical researchers developing treatments for central nervous system disorders.
2 investors
CureApp HT is a smartphone application that helps patients manage hypertension through self-monitoring of blood pressure and lifestyle changes, with supporting guidance from physicians. The 6-month program is designed for adults with essential hypertension and is registered as a medical device in Japan.
2 investors
Curve Health operates a telemedicine platform combined with data analytics and health information exchange that connects bedside providers with remote clinicians. It focuses on long-term care, serving nursing home and skilled nursing facility residents, their caregivers, and clinicians.
2 investors
CustoMED develops an AI-powered platform for personalized surgery that enables hospitals and 3D labs to scale surgical customization with reduced manual labor and cost.
2 investors
Cyberdyne develops HAL, a wearable cyborg exoskeleton that detects bioelectric signals from the wearer's muscles and assists or augments physical movement. The technology is applied across medical, healthcare, caregiving, industrial, construction, and disaster recovery sectors.
2 investors
Cybrexa is a biotechnology company developing cancer therapeutics that use its alphalex peptide-drug conjugate platform to target the low-pH tumor microenvironment for selective delivery. The technology aims to enable more potent drugs and combination therapies and to expand the efficacy of existing anticancer agents.
2 investors
CytoGen Lab develops liquid biopsy technology for cancer detection through circulating tumor cell (CTC) isolation from blood samples, combining biotechnology and engineering for precision medicine applications.
2 investors
D-NOME develops molecular reagent technologies aimed at making diagnostics more affordable and accessible. Founded in 2021, the company builds bio-technologies for the diagnostics and healthcare sector.
2 investors
Dane Technologies develops autonomous mobile robots for supply chain and retail automation, partnering with leaders in autonomy, vision, and mobility to power their product family.
2 investors
Dante Labs provides clinical-grade whole genome sequencing services for individuals seeking genetic insights into hereditary disease risk, diagnostic clarity for unexplained symptoms, treatment optimization, and proactive health planning. The company delivers comprehensive genomic analysis as an alternative to limited consumer DNA tests, with results presented in 200+ physician-ready clinical reports.
2 investors
Data Innovations builds laboratory middleware that connects lab instruments, LIS, and EMR/EHR systems across disciplines, consolidating testing control into one platform. Its Instrument Manager offers autoverification, customizable rules, specimen management, and lab intelligence for clinical laboratories.
2 investors
Decimal Code provides revenue cycle AI solutions for healthcare organizations, leveraging machine learning to optimize medical coding, prior authorization, and billing processes. The company's platform is built on 15 million de-identified cases from 84 research hospitals and is designed for hospital finance teams and revenue cycle managers.
2 investors
Dedicated Computing designs and manufactures customized computing platforms for mission-critical equipment in healthcare, training, and industrial automation sectors. The company provides engineering, prototyping, certification, and lifecycle management services to global OEMs building life-saving or training devices.
2 investors
DeepEcho develops AI-powered intelligent ultrasound technology to detect birth defects, preterm birth, and low birth weight in newborns. The solution uses deep learning algorithms to help reduce preventable child mortality.
2 investors
DEWI11 is an online gaming platform that provides information and articles about online games, including game updates, seasonal changes, new features, and strategies for players.
2 investors
Delpor develops subcutaneous implant devices that deliver therapeutic drugs over extended periods (6-12 months) for chronic condition treatment. The company's passive implant technology enables sustained-release drug delivery through simple in-office procedures, targeting improved patient adherence and consistent pharmacokinetic profiles.
2 investors
AMR Bio is a clinical-phase biotechnology company developing novel anti-infective drugs focused on infection prevention and combating antibiotic resistance.
2 investors
Detect develops a point-of-care molecular diagnostics platform for women's health applications. The company brings laboratory-quality testing capabilities to clinical settings closer to patients.
2 investors
Devoro Medical developed the WOLF Thrombectomy Platform, a non-console, lytic-free medical device that uses finger-like prongs to capture and remove blood clots (thrombi) from the arterial and venous systems. The technology serves physicians performing thrombectomy procedures for clot management.
2 investors
Dia Beta Labs is a drug discovery and development company focused on diabetes and obesity research. The company leverages academic expertise and scientific innovation in these therapeutic areas.
2 investors